Defining the current role of immune checkpoint inhibitors in the treatment of mismatch repair-deficient/microsatellite stability-high colorectal cancer and shedding light on future approaches-Reference-Cited by-同舟云学术

Defining the current role of immune checkpoint inhibitors in the treatment of mismatch repair-deficient/microsatellite stability-high colorectal cancer and shedding light on future approaches

Published:2021-02-18 Issue:7 Volume:15 Page:735-742
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Tan Elaine¹,Sahin Ibrahim Halil¹

Affiliation:

1. Department of Gastrointestinal Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Funder

not funded

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2021.1886077

Reference48 articles.

1. Cancer statistics, 2020

2. Ahnen DJ, Wade SW, Jones WF, et al. The increasing incidence of young-onset colorectal cancer: a call to action. In: Mayo Clinic Proceedings. (Ed.^(Eds) (Elsevier, 2014) 216–224.

3. Young-Onset Colorectal Cancer: Is It Time to Pay Attention?

4. Precision medicine for metastatic colorectal cancer: an evolving era

5. The consensus molecular subtypes of colorectal cancer

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-associated mesenchymal stromal cells modulate macrophage phagocytosis in stromal-rich colorectal cancer via PD-1 signaling;iScience;2024-09

2. Neoadjuvant immunotherapy in a locally advanced colon cancer patient with MSI-H and suspected Lynch syndrome: A case report;Zeitschrift für Gastroenterologie;2024-04-11

3. Immunotherapy in pMMR/MSS Metastatic Colorectal Cancer;Nature Cell and Science;2024-03-30

4. Grid2 interacting protein is a potential biomarker related to immune infiltration in colorectal cancer;European Journal of Medical Research;2023-11-14

5. Immune checkpoint inhibitors in BRAF-mutated advanced colorectal cancer;Future Oncology;2023-11